Exelixis, Inc.

DB:EX9 Stock Report

Market Cap: €9.9b

Exelixis Future Growth

Future criteria checks 2/6

Exelixis is forecast to grow earnings and revenue by 15.6% and 8.4% per annum respectively. EPS is expected to grow by 16.7% per annum. Return on equity is forecast to be 12.8% in 3 years.

Key information

15.6%

Earnings growth rate

16.7%

EPS growth rate

Biotechs earnings growth42.4%
Revenue growth rate8.4%
Future return on equity12.8%
Analyst coverage

Good

Last updated25 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:EX9 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,43064356393715
12/31/20252,18449849366821
12/31/20242,16250635345118
9/30/20242,082467405470N/A
6/30/20242,014350166316N/A
3/31/20241,847205185318N/A
12/31/20231,830208170333N/A
9/30/20231,77492134396N/A
6/30/20231,714164213389N/A
3/31/20231,664154118299N/A
12/31/20221,611182224363N/A
9/30/20221,638308343385N/A
6/30/20221,555273310359N/A
3/31/20221,521298453509N/A
12/31/20211,435231337401N/A
9/30/20211,254164275338N/A
6/30/20211,15794218272N/A
3/31/20211,03165152192N/A
12/31/2020988112179209N/A
9/30/2020958152310334N/A
6/30/2020998282372391N/A
3/31/2020979294408421N/A
12/31/2019968321514527N/A
9/30/2019956612465474N/A
6/30/2019910642541563N/A
3/31/2019856650473506N/A
12/31/2018854690382416N/A
9/30/2018745368316364N/A
6/30/2018672323N/A237N/A
3/31/2018585253N/A169N/A
12/31/2017452154N/A166N/A
9/30/2017410150N/A197N/A
6/30/201732058N/A154N/A
3/31/20172576N/A122N/A
12/31/2016191-70N/A210N/A
9/30/2016124-147N/A90N/A
6/30/201671-181N/A61N/A
3/31/201643-186N/A60N/A
12/31/201537-162N/A-141N/A
9/30/201535-178N/A-156N/A
6/30/201531-195N/A-180N/A
3/31/201530-229N/A-208N/A
12/31/201425-261N/A-235N/A
9/30/201422-281N/A-233N/A
6/30/201421-286N/A-232N/A
3/31/201427-275N/A-216N/A
12/31/201331-245N/A-199N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: EX9's forecast earnings growth (15.6% per year) is above the savings rate (1%).

Earnings vs Market: EX9's earnings (15.6% per year) are forecast to grow slower than the German market (20.9% per year).

High Growth Earnings: EX9's earnings are forecast to grow, but not significantly.

Revenue vs Market: EX9's revenue (8.4% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: EX9's revenue (8.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: EX9's Return on Equity is forecast to be low in 3 years time (12.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y